Healthcare


 UnitedHealth Group (NYSE: UNH) Reports Strong First Quarter 2024 Performance Amid Cyberattack Challenges

UnitedHealth Group (NYSE: UNH) Reports Strong First Quarter 2024 Per...

April 17, 2024 03:56 PM AEST | By Team Kalkine Media

UnitedHealth Group (,NYSE: UNH,), a prominent player in the healthcare and well-being sector, disclosed its first quarter 2024 earnings report on Apri...

 Roche's Breakthrough Blood Test for Alzheimer's Receives FDA Designation

Roche's Breakthrough Blood Test for Alzheimer's Receives FDA Designa...

April 12, 2024 07:27 AM AEST | By Team Kalkine Media

Roche (SIX: RO, ROG; OTCQX:,RHHBY,), with over 20 years of dedicated scientific research in Alzheimer's disease, is committed to advancing detection m...

 What made Moderna stock pop 10% on Tuesday?

What made Moderna stock pop 10% on Tuesday?

April 10, 2024 02:37 AM AEST | By Invezz

Moderna Inc (NASDAQ: MRNA) popped as much as 10% on Tuesday after a Jefferies analyst made upbeat remarks on new data for its experimental vaccine for...

 Ocugen stock price is flying: beware of this crucial OCGN risk

Ocugen stock price is flying: beware of this crucial OCGN risk

April 07, 2024 06:06 PM AEST | By Invezz

Ocugen (NASDAQ: OCGN) stock price has been one of the best-performing companies in Wall Street this year. It has jumped by more than 218% in 2024, bea...

 Candel Therapeutics stock soars 30%: find out more

Candel Therapeutics stock soars 30%: find out more

April 05, 2024 11:28 PM AEDT | By Invezz

Candel Therapeutics Inc is up roughly 30% in premarket on Friday after reporting positive interim data for its experimental treatment of non-metastati...

 Johnson & Johnson to buy Shockwave Medical for $12.5 billion

Johnson & Johnson to buy Shockwave Medical for $12.5 billion

April 05, 2024 10:18 PM AEDT | By Invezz

Shockwave Medical Inc (NASDAQ: SWAV) is in the green today after Johnson & Johnson (NYSE: JNJ) said it will buy the medical device maker for $12.5...

 Top three US healthcare stocks to buy in April

Top three US healthcare stocks to buy in April

April 04, 2024 07:54 PM AEDT | By Invezz

As we look forward to celebrating World Health Day on April 7th, these are the top three healthcare US companies we think you should be watching for y...

 Amcor Powers Up for Healthcare Boom: Expands Thermoforming Capacity in North America

Amcor Powers Up for Healthcare Boom: Expands Thermoforming Capacity...

February 01, 2024 07:32 PM AEDT | By Team Kalkine Media

Amcor, a global leader in packaging solutions, has recently revealed plans to expand its thermoforming production capacity in North America. This stra...

 Cramer reacts to Eli Lilly’s telehealth service for weight-loss drug

Cramer reacts to Eli Lilly’s telehealth service for weight-loss drug

January 05, 2024 09:29 AM AEDT | By Invezz

Eli Lilly & Co (NYSE: LLY) was the talk of the market on Thursday after the pharmaceutical giant launched LillyDirect – a website that will enable...

 After a bruising 2023, Bristol-Myers Squibb (BMY) forges a risky M&A strategy

After a bruising 2023, Bristol-Myers Squibb (BMY) forges a risky M&A...

December 27, 2023 03:02 PM AEDT | By Invezz

Bristol-Myers Squibb (NYSE: BMY), the giant pharmaceutical company, had a difficult year as its stock tanked. Its shares crashed by over 28% in 2023,...

 AbbVie bolsters portfolio with $10.1 billion ImmunoGen buyout for cancer therapy

AbbVie bolsters portfolio with $10.1 billion ImmunoGen buyout for ca...

December 02, 2023 12:50 AM AEDT | By Invezz

AbbVie has announced its acquisition of ImmunoGen for $10.1 billion in cash, marking a strategic move amidst rising competition for their leading trea...

 Days after US and UK approval, Eli Lilly’s Tirzepatide approved in the EU

Days after US and UK approval, Eli Lilly’s Tirzepatide approved in t...

November 11, 2023 05:05 AM AEDT | By Invezz

Eli Lilly (LLY) stock price movement has experienced a whirlwind since Wednesday’s approval of its diabetes medication, tirzepatide, for chronic...

 Find out why these biotechnology firms surpassed market gains

Find out why these biotechnology firms surpassed market gains

October 20, 2023 09:06 PM AEDT | By Akanksha Vashisht

Summary,The Nasdaq composite index fell by 1% on Thursday.,Cidara Therapeutics Inc. reported a revenue of US$7.6 million for Q2 2023.,INmune Bio Inc....

 These Nasdaq-listed healthcare stocks beat Monday’s market gains

These Nasdaq-listed healthcare stocks beat Monday’s market gains

October 03, 2023 09:38 PM AEDT | By Akanksha Vashisht

Summary,The Nasdaq Composite Index rose by 0.67% on Monday, while the Nasdaq Healthcare Index fell by 0.67%.,Spok Holdings Inc., a healthcare communic...

 Blue Shield of California to trim its partnership with CVS Health

Blue Shield of California to trim its partnership with CVS Health

August 18, 2023 03:16 AM AEST | By Invezz

Blue Shield of California plans on trimming its partnership with CVS Health Corp (NYSE: CVS) to cut costs. Shares of the healthcare company are down 8...

 UNH wins provisional clearance from U.K. CMA to acquire EMIS

UNH wins provisional clearance from U.K. CMA to acquire EMIS

August 12, 2023 03:03 AM AEST | By Invezz

UnitedHealth Group Inc (NYSE: UNH) is in the green this morning after the British regulator provisionally cleared its £1.2 billion acquisition of...

 Eli Lilly stock is a ‘buy’ after its blockbuster Q2

Eli Lilly stock is a ‘buy’ after its blockbuster Q2

August 10, 2023 02:44 AM AEST | By Invezz

Eli Lilly & Co (NYSE: LLY) has already gained 45% year-to-date but a Jefferies analyst is convinced that the stock is not out of juice just yet. E...

 Novo Nordisk shares jump another 17% on the back of obesity drug

Novo Nordisk shares jump another 17% on the back of obesity drug

August 09, 2023 01:20 AM AEST | By Invezz

Shares of Novo Nordisk A/S (NYSE: NVO) are up 17% this morning after the pharmaceutical behemoth reported results of its “SELECT” trial. W...

 Hims & Hers stock price has gone parabolic: Is it a good buy?

Hims & Hers stock price has gone parabolic: Is it a good buy?

August 08, 2023 10:30 PM AEST | By Invezz

Hims & Hers (NYSE: HIMS) stock price bounced back after the company published strong results and boosted its forward guidance. The shares closed t...

 As Cassava Sciences (SAVA) stock slips, is it safe to buy the dip?

As Cassava Sciences (SAVA) stock slips, is it safe to buy the dip?

August 08, 2023 03:14 AM AEST | By Invezz

Cassava Sciences (NASDAQ: SAVA) stock price sell-off intensified as the recent momentum faded. SAVA shares plunged to a low of $18.30 on Monday, the l...

Recent Articles

 ZIM stock price spikes amid dividend hopes but there’s a key risk
April 27, 2024 03:25 AM AEST | By Invezz

 Buy AMD May 17 Put Option: Use the short-term bounce as an opportunity to go short
April 27, 2024 02:24 AM AEST | By Invezz

 Xpeng announces Mona: a sub-brand of lower priced electric vehicles
April 27, 2024 01:52 AM AEST | By Invezz

 Short LSCC: Bounce back going into earnings might not last.
April 27, 2024 01:35 AM AEST | By Invezz

 Intel stock: don’t hold your breath for a swift recovery
April 27, 2024 01:07 AM AEST | By Invezz